Drug Companies Create Academic Partnerships

Plagued by product failures and research disappointments, the drug industry is going back to school—literally. There's no guarantee the partnerships will solve the drug drought. And there are many logistical hurdles. Past deals between industry and academia have been hampered by patent disputes and tussles over publication rights, as companies tried to thwart academics who want to share their discoveries with colleagues around the world. So now the companies have devised policies allowing their Ivory Tower partners to patent and publish their discoveries, even as they draw the professors more deeply into corporate affairs. Read more at:
http://www.businessweek.com/magazine/content/08_20/b4084032485505.htm?chan=magazine+channel_news